Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Sold by Crossmark Global Holdings Inc.

Crossmark Global Holdings Inc. cut its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 9.2% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,637 shares of the company’s stock after selling 671 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Acadia Healthcare were worth $448,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of ACHC. Principal Financial Group Inc. boosted its holdings in Acadia Healthcare by 19.4% in the second quarter. Principal Financial Group Inc. now owns 643,521 shares of the company’s stock valued at $43,463,000 after purchasing an additional 104,359 shares during the period. Innealta Capital LLC purchased a new position in shares of Acadia Healthcare in the 2nd quarter valued at about $164,000. Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of Acadia Healthcare by 46.0% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 27,483 shares of the company’s stock worth $1,856,000 after buying an additional 8,657 shares in the last quarter. Verdence Capital Advisors LLC purchased a new stake in shares of Acadia Healthcare during the second quarter worth approximately $237,000. Finally, Bank of New York Mellon Corp raised its holdings in Acadia Healthcare by 6.6% in the second quarter. Bank of New York Mellon Corp now owns 1,249,369 shares of the company’s stock valued at $84,382,000 after acquiring an additional 77,509 shares in the last quarter.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a report on Friday, August 2nd. TD Cowen decreased their price target on Acadia Healthcare from $101.00 to $91.00 and set a “buy” rating for the company in a report on Friday, May 17th. Royal Bank of Canada reissued an “outperform” rating and set a $94.00 target price on shares of Acadia Healthcare in a research report on Wednesday, May 22nd. Barclays lowered their price target on Acadia Healthcare from $89.00 to $83.00 and set an “overweight” rating for the company in a report on Thursday, August 1st. Finally, Cantor Fitzgerald reissued a “neutral” rating and set a $90.00 price objective on shares of Acadia Healthcare in a report on Monday, August 19th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $87.44.

Acadia Healthcare Stock Performance

Shares of ACHC opened at $81.93 on Tuesday. The company’s 50 day simple moving average is $70.45 and its 200-day simple moving average is $72.55. Acadia Healthcare Company, Inc. has a 12-month low of $62.04 and a 12-month high of $87.77. The firm has a market cap of $7.60 billion, a PE ratio of -585.21, a price-to-earnings-growth ratio of 2.36 and a beta of 1.32. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, July 31st. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The company had revenue of $796.00 million for the quarter, compared to analyst estimates of $784.38 million. During the same period in the previous year, the business posted $0.92 earnings per share. Acadia Healthcare’s quarterly revenue was up 8.8% on a year-over-year basis. As a group, equities analysts predict that Acadia Healthcare Company, Inc. will post 3.51 EPS for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.